Metformin limits the adipocyte tumor-promoting effect on ovarian cancer.
about
Targeting Stromal-Cancer Cell Crosstalk Networks in Ovarian Cancer TreatmentMolecular pathways: trafficking of metabolic resources in the tumor microenvironmentOld drug, new trick: repurposing metformin for gynecologic cancers?Insulin-Sensitizers, Polycystic Ovary Syndrome and Gynaecological Cancer RiskGenomic Characterization of Metformin Hepatic ResponseDietary energy balance modulates ovarian cancer progression and metastasis.Targeting exosomes from preadipocytes inhibits preadipocyte to cancer stem cell signaling in early-stage breast cancerIn Vitro and In Vivo Effects of Metformin on Osteopontin Expression in Mice Adipose-Derived Multipotent Stromal Cells and Adipose TissueTargeting AMPK for cancer prevention and treatment.Metformin prevents aggressive ovarian cancer growth driven by high-energy diet: similarity with calorie restriction.Cellular and molecular processes in ovarian cancer metastasis. A Review in the Theme: Cell and Molecular Processes in Cancer Metastasis.Obesity Contributes to Ovarian Cancer Metastatic Success through Increased Lipogenesis, Enhanced Vascularity, and Decreased Infiltration of M1 Macrophages.Role of cystathionine beta synthase in lipid metabolism in ovarian cancerDeoxypodophyllotoxin suppresses tumor vasculature in HUVECs by promoting cytoskeleton remodeling through LKB1-AMPK dependent Rho A activatio.Targeting AMPK signaling in combating ovarian cancers: opportunities and challenges.Everolimus exhibits anti-tumorigenic activity in obesity-induced ovarian cancer.Mechanisms linking obesity to altered metabolism in mice colon carcinogenesis.Local adipocyte cancer cell paracrine loop: can "sick fat" be more detrimental?Complex I inhibition augments dichloroacetate cytotoxicity through enhancing oxidative stress in VM-M3 glioblastoma cells.Deficiency of AMPK in CD8+ T cells suppresses their anti-tumor function by inducing protein phosphatase-mediated cell death.Metabolic Cooperation and Competition in the Tumor Microenvironment: Implications for Therapy.5-Aminoimidazole-4-carboxamide ribonucleoside-mediated adenosine monophosphate-activated protein kinase activation induces protective innate responses in bacterial endophthalmitis.Hyperactive mTORC1 signaling is unaffected by metformin treatment in aged skeletal muscle.Bioenergetic Adaptations in Chemoresistant Ovarian Cancer Cells.Phenformin has anti-tumorigenic effects in human ovarian cancer cells and in an orthotopic mouse model of serous ovarian cancer.Adipocyte microenvironment promotes Bclxl expression and confers chemoresistance in ovarian cancer cells.Dual Effects of Metformin on Adipogenic Differentiation of 3T3-L1 Preadipocyte in AMPK-Dependent and Independent Manners.
P2860
Q26769963-988A083B-7371-429C-95DA-0260796B3026Q26825620-1DE97CCA-C061-4A1C-A383-BF155D3859D6Q27010558-C7C560B0-6D75-48EE-B73C-A2B6C77498ECQ28072521-E0820674-4DA3-4F26-B03C-8B0EB336BE80Q28554592-96A70176-338A-4616-9358-3CF6A45AFD8EQ34227594-50648B34-1320-4777-95B8-E2DD7183F32EQ35269645-4F11CC39-6282-45DE-8363-63AE066AC6A9Q35603472-6A0094BD-C9A8-4EC0-B866-0A09EAA559F9Q35781311-816964CF-20B1-4844-9BA8-FBA007C25941Q35793665-B9B22EF1-8906-4D95-AED8-B8261D154976Q36122605-F458DEB1-AD4E-40A1-A3DA-F37C1DFB740AQ36342802-32CBEF52-E199-402E-A309-0BC4E1D8D2C8Q36545745-EBD6780B-F020-4440-8135-C45DD45B7053Q36557347-3AA3A82E-6BDE-4BF1-876D-BBED728C95E7Q36949580-BF0BD1BD-9276-45C6-A0CE-F1F33D1BB6BFQ37190310-7EA1B3BD-90DA-412D-ABA5-93BD097661EEQ38262172-451E4D4F-1348-474F-B8E1-94C74EB6C4C5Q38381446-7B8D1848-9555-48AD-AA0C-18184EF6EDFFQ38711927-C583CEC7-CD7B-4621-97B0-1E92E809DFECQ38901228-99C59F18-750E-4A4C-8451-47CD55D03F29Q39265746-E1D4D307-6887-4B14-876D-305EA9DB5BF1Q40644641-AAFAD95F-D41E-4956-B8A7-8DA14660FD35Q40995740-D25BB680-4A47-468B-9906-42962D9C2FE1Q41458947-F02891BF-084C-46D6-BCC7-74C2CB5A29E1Q47098834-EA35FCEE-64B3-4411-812E-94614DC61326Q51238643-D399962C-CB62-4E91-BC4F-5ED4E173DF0BQ54978492-6E4C3D4E-BD62-4E7E-8DDC-2446AC6A5F31
P2860
Metformin limits the adipocyte tumor-promoting effect on ovarian cancer.
description
2014 nî lūn-bûn
@nan
2014 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Metformin limits the adipocyte tumor-promoting effect on ovarian cancer.
@ast
Metformin limits the adipocyte tumor-promoting effect on ovarian cancer.
@en
Metformin limits the adipocyte tumor-promoting effect on ovarian cancer.
@nl
type
label
Metformin limits the adipocyte tumor-promoting effect on ovarian cancer.
@ast
Metformin limits the adipocyte tumor-promoting effect on ovarian cancer.
@en
Metformin limits the adipocyte tumor-promoting effect on ovarian cancer.
@nl
prefLabel
Metformin limits the adipocyte tumor-promoting effect on ovarian cancer.
@ast
Metformin limits the adipocyte tumor-promoting effect on ovarian cancer.
@en
Metformin limits the adipocyte tumor-promoting effect on ovarian cancer.
@nl
P2093
P2860
P356
P1433
P1476
Metformin limits the adipocyte tumor-promoting effect on ovarian cancer
@en
P2093
Adnan R Munkarah
Calvin Tebbe
Jasdeep Chhina
Kalli Sarigiannis
Ramandeep Rattan
Shailendra Giri
P2860
P304
P356
10.18632/ONCOTARGET.2012
P407
P577
2014-07-01T00:00:00Z